Skip to content

The Application of Percutaneous Electroacupuncture on Zusanli Point in Elderly Patients with Endoscopic Retrograde Cholangiopancreatography (ERCP)

The Application of Percutaneous Electroacupuncture on Zusanli Point in Elderly Patients with Endoscopic Retrograde Cholangiopancreatography (ERCP)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013142
Enrollment
Unknown
Registered
2017-10-28
Start date
2017-11-30
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic bilibry disease

Interventions

A group:acupuncture Zusanli (ST 36)
B group:Nonacupiont stimulus

Sponsors

Tianjin Central Hospital for Gynecology & Obstetrics
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 87 Years

Inclusion criteria

Inclusion criteria: 1. Patients with ERCP surgery were chosen; 2. ASA II; 3. Some patients combined with hypertension(I-II),diabete, coronary heart disease; 4. Estimated time of operation=1.5h.;Inclusion criteria: 1. Patients with ERCP surgery were chosen; 2. ASA II; 3. Some patients combined with hypertension(I-II),diabete, coronary heart disease; 4. Estimated time of operation=1.5h.;Inclusion criteria: 1. Patients with ERCP surgery were chosen; 2. ASA II; 3. Some patients combined with hypertension(I-II),diabete, coronary heart disease; 4. Estimated time of operation=1.5h.;Inclusion criteria: 1. Patients with ERCP surgery were chosen; 2. ASA II; 3. Some patients combined with hypertension(I-II),diabete, coronary heart disease; 4. Estimated time of operation=1.5h.;Inclusion criteria: 1. Patients with ERCP surgery were chosen; 2. ASA II; 3. Some patients combined with hypertension(I-II),diabete, coronary heart disease; 4. Estimated time of operation=1.5h.

Exclusion criteria

Exclusion criteria: 1. Patienrs with severe cardiovascular disease; 2. Take steroids recently; 3. Abnormal coagulation function.;Exclusion criteria: 1. Patienrs with severe cardiovascular disease; 2. Take steroids recently; 3. Abnormal coagulation function.;Exclusion criteria: 1. Patienrs with severe cardiovascular disease; 2. Take steroids recently; 3. Abnormal coagulation function.;Exclusion criteria: 1. Patienrs with severe cardiovascular disease; 2. Take steroids recently; 3. Abnormal coagulation function.;Exclusion criteria: 1. Patienrs with severe cardiovascular disease; 2. Take steroids recently; 3. Abnormal coagulation function.

Design outcomes

Primary

MeasureTime frame
Cor;NE;E;

Countries

China

Contacts

Public ContactLi Li;Li Li;Li Li;Li Li;Li Li ;;;;

Tianjin Central Hospital for Gynecology & Obstetrics;Tianjin Central Hospital for Gynecology & Obstetrics;Tianjin Central Hospital for Gynecology & Obstetrics;Tianjin Central Hospital for Gynecology & Obstetrics;Tianjin Central Hospital for Gynecology & Obstetrics

zxfclili@sina.com;zxfclili@sina.com;zxfclili@sina.com;zxfclili@sina.com;zxfclili@sina.com+86 13821688264;+86 13821688264;+86 13821688264;+86 13821688264;+86 13821688264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026